[1]
Nabila akram et al. 2025. MOLECULAR AND CLINICOPATHOLOGIC HETEROGENEITY OF IGM-NEGATIVE LYMPHOPLASMACYTIC LYMPHOMA: INSIGHTS FROM A PAKISTANI MULTICENTER STUDY. Journal of Population Therapeutics and Clinical Pharmacology. 32, 10 (Nov. 2025), 1097–1107. DOI:https://doi.org/10.53555/vrm3je10.